Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, CAR-T cell therapy research, and Chronic Lymphocytic Leukemia Research.
Epixtract: An Artificial Intelligence-Driven Tool to Optimize Data Abstraction for CIBMTR Reporting
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia
Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT
Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy
Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy
Non-response to bridging therapy prior to CAR-T is associated with increased toxicity and adverse outcomes in Relapsed/Refractory multiple myeloma (RRMM)
Dynamics of B Cell Maturation Antigen (BCMA) Expression Pre-Treatment and at Relapse in Patients with Relapsed/Refractory Multiple Myeloma Receiving BCMA Directed CAR-T Cell Therapy
Clonal Hematopoiesis Underlies Prolonged Cytopenias after Anti-BCMA CAR-T Therapy
Real-world adherence and tolerability of FLT3 inhibitors as post-allogeneic transplant maintenance therapy in older adults with AML: A Medicare claims data cohort study.
Allogeneic hematopoietic cell transplantation for acute leukemia patients not in complete remission.
The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission
Multi-omic single cell sequencing reveals discordant MRD and mechanisms of relapse in pediatric AML
CORAL: Expert-Curated Oncology Reports to Advance Language Model Inference
A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry
Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia
Indolent CD8+ CAR T-Cell Lymphoma of the Gastrointestinal Tract after Ciltacabtagene Autoleucel Therapy for Relapsed/Refractory Multiple Myeloma
Microfluidics-free single-cell genomics with templated emulsification
LNK/<i>SH2B3</i> as a novel driver in juvenile myelomonocytic leukemia
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy
Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma
Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma
VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis
Frontline treatment patterns and outcomes among older adults with acute myeloid leukemia: A population‐based analysis in the modern era
FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia